Michael Seifert, Ph.D.
© Michael Seifert
Group leader
NameMr PD Dr. rer. nat. habil. Michael Seifert
Send encrypted email via the SecureMail portal (for TUD external users only).
Michael Seifert is the head of the research group Medical Bioinformatics at the Institute for Medical Informatics and Biometry. His tasks include the development of computational tools for the integrative analysis of molecular data and the provision of a bioinformatics data analysis service. Details to the specific research focus are provided on the web page of the research group.
Publications
2025
-
Human fingertip regeneration follows clinical phases with distinct proteomic signatures – a Comprehensive MS/MS analysis, 10 Jun 2025Electronic (full-text) versionResearch output: Preprint/documentation/report > Preprint
2024
-
Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles, 13 May 2024, In: Biology direct. 19, 1, 15 p., 38Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs, 24 Apr 2024, In: Acta neuropathologica communications. 12, 1, p. 67, 67Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome, 21 Feb 2024, In: Molecular cancer. 23(2024), 1, 25 p., 39Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
Network-based analysis of heterogeneous patient-matched brain and extracranial melanoma metastasis pairs reveals three homogeneous subgroups, 17 Feb 2024, In: Computational and Structural Biotechnology Journal. 23 (2024), p. 1036-1050, 15 p.Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
β1 integrin mediates unresponsiveness to PI3Kα inhibition for radiochemosensitization of 3D HNSCC models, Feb 2024, In: Biomedicine & pharmacotherapy. 171 (2024), 13 p., 116217Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactions, 22 Jan 2024, In: Journal of Experimental and Clinical Cancer Research. 43(2024), 1, 17 p., 25Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
Comparative analysis of neurofilaments and biomarkers of muscular damage in amyotrophic lateral sclerosis, 2024, In: Brain Communications. 6, 5, fcae288Electronic (full-text) versionResearch output: Contribution to journal > Research article
2023
-
Screen time and sleep among medical students in Germany, 19 Sep 2023, In: Scientific reports. 13, 1, 15462Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification, 2 Aug 2023, In: Nature communications. 14, 1, 4632Electronic (full-text) versionResearch output: Contribution to journal > Research article